Skip to main content
. 2023 Feb 17;14:1096826. doi: 10.3389/fmicb.2023.1096826

Figure 5.

Figure 5

Anticancer activity of Glutamicibacter mysorens strain protein. MTT assay performed by using prostate cancer PC3 cell line. (A) Untreated cells of PC3 cell line, (B) Standard cisplatin at 5 μg/ml, (C) 56% Anticancer activity of Glutamicibacter mysorens protein at 200 μg/ml.